Business
Nike’s China Recovery Slows as Sales Plunge 20% in Critical Market
🎧 Listen:By Inti Pacheco | April 01, 2026Nike's China Sales Plunge 20% as Local Competition Heats UpNike's sales in China...
Cal-Maine Foods Profit and Sales Plummet as Egg Prices Correct Sharply
🎧 Listen:By Connor Hart | April 01, 2026CAL-MAINE FOODS— Cal-Maine Foods (CALM) saw its shares rise 7.1% following its fiscal...
Volvo Boosts Polestar Investment Via Debt Conversion, Secures U.S. Manufacturing Deal
🎧 Listen:By Dominic Chopping | April 01, 2026Volvo Car Converts $1.1 Billion in Loans to Equity in Polestar, Boosting StakeVolvo...
DoorDash Fuels Autonomous Delivery Ambitions With $200 Million Investment in EV Startup Also
🎧 Listen:By Nicholas G. Miller | April 01, 2026DOORDASH— DoorDash, a leading food delivery platform, has committed $200 million to...
Beyond Meat Struggles With Declining Sales and Growing Accounting Concerns
🎧 Listen:By Katherine Hamilton | April 01, 2026Beyond Meat Faces Further Financial Scrutiny Amidst Declining Sales and Missed Filing Deadline...
RH Faces Revenue Slump as Tariffs and Weather Hit Fourth Quarter Results
🎧 Listen:By Elias Schisgall | April 01, 2026RH Reports $1.46 Earnings Per Share, a 111% Increase Amidst Tariff and Weather...
Hershey Eyes Snack Expansion Beyond Chocolate with Better-for-You Push
🎧 Listen:By Connor Hart | April 01, 2026Hershey Aims for 10%+ Profit Growth by Investing in Better-for-You SnacksHershey is targeting...
2026 Sees Unprecedented Surge in Large Corporate Deals
🎧 Listen:By Lauren Thomas | April 01, 2026MERGERS AND ACQUISITIONS— 22 large corporate deals valued at $10 billion or more...
McCormick’s Remarkable Ascent: From 1889 Baltimore Startup to $65 Billion Global Food Leader
🎧 Listen:By Amira McKee | April 01, 2026McCormick's 1889 Genesis: How a $65 Billion Global Food Power Began McCormick's journey...
Pharmaceutical Giants Adopt More Cautious M&A Approach
🎧 Listen:By Xavier Martinez | March 31, 2026NEW YORK— Pharmaceutical Deal Activity Drops Below $10 Billion ThresholdBig drugmakers are taking...